MedTrace Logo

Primary Insufficiency of the GSV With a Diameter >/= 12 mm, Antero-lateral Branches, or Below the Knee

NCT02345018 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-04-27

No results posted yet for this study

Summary

The goal of this registry study is to provide insight in the safety and efficacy of treatment with MOCA for primary insufficiency of the GSV with a diameter \>/=12mm, insufficient antero-lateral branches and insufficiency of the GSV below the knee.

Conditions

  • Varicose Veins
  • Dilated Veins

Interventions

PROCEDURE

Mechano-chemical ablation

Treatment with mechano-chemical ablation

Sponsors & Collaborators

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • Michel Reijnen, MD, PhD · Rijnstate Hospital

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02345018 on ClinicalTrials.gov